Serial 88171100
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 20 Nov 2025)
What this means for you
Registered since 30 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88171100
- Registration number
- 5823425
- Mark type
- Design / logo
- Filed
- 26 Oct 2018
- Published for opposition
- 26 Mar 2019
- Registered
- 30 Jul 2019
- Attorney of record
- Sonali S. Srivastava
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- AbbVie Biotechnology Ltd, Hamilton, BM
- AbbVie Biotechnology Ltd, Hamilton, BM
- AbbVie Biotechnology Ltd, Hamilton, BM
Prosecution history
- 20 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Nov 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Jul 2025 — TEAS SECTION 8 & 15 RECEIVED
- 30 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 22 Jun 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Jun 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 21 May 2019 — USE AMENDMENT FILED
- 03 Jun 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 May 2019 — TEAS STATEMENT OF USE RECEIVED
- 21 May 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Mar 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Mar 2019 — PUBLISHED FOR OPPOSITION